154 related articles for article (PubMed ID: 20716857)
1. Advanced research on dopamine signaling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia.
Itokawa M; Arinami T; Toru M
J Pharmacol Sci; 2010; 114(1):1-5. PubMed ID: 20716857
[TBL] [Abstract][Full Text] [Related]
2. A structural polymorphism of human dopamine D2 receptor, D2(Ser311-->Cys).
Itokawa M; Arinami T; Futamura N; Hamaguchi H; Toru M
Biochem Biophys Res Commun; 1993 Nov; 196(3):1369-75. PubMed ID: 7902708
[TBL] [Abstract][Full Text] [Related]
3. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis.
Jönsson EG; Sillén A; Vares M; Ekholm B; Terenius L; Sedvall GC
Am J Med Genet B Neuropsychiatr Genet; 2003 May; 119B(1):28-34. PubMed ID: 12707934
[TBL] [Abstract][Full Text] [Related]
5. An association study between the Cys311 variant of dopamine D2 receptor gene and schizophrenia in the Okinawan population.
Kaneshima M; Higa T; Nakamoto H; Nagamine M
Psychiatry Clin Neurosci; 1997 Dec; 51(6):379-81. PubMed ID: 9472122
[TBL] [Abstract][Full Text] [Related]
6. No association of dopamine D2 receptor molecular variant Cys311 and schizophrenia in Chinese patients.
Chen CH; Chien SH; Hwu HG
Am J Med Genet; 1996 Jul; 67(4):418-20. PubMed ID: 8837714
[TBL] [Abstract][Full Text] [Related]
7. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia.
Hattori M; Nanko S; Dai XY; Fukuda R; Kazamatsuri H
Biochem Biophys Res Commun; 1994 Jul; 202(2):757-63. PubMed ID: 7914079
[TBL] [Abstract][Full Text] [Related]
8. Further evidence supporting the association between the dopamine receptor D2 Ser/Cys311 variant and disorganized symptomatology of schizophrenia.
Serretti A; Lilli R; Lorenzi C; Smeraldi E
Schizophr Res; 2000 Jun; 43(2-3):161-2. PubMed ID: 11001590
[No Abstract] [Full Text] [Related]
9. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
[TBL] [Abstract][Full Text] [Related]
10. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses.
Glatt SJ; Jönsson EG
Am J Med Genet B Neuropsychiatr Genet; 2006 Mar; 141B(2):149-54. PubMed ID: 16402354
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between dopamine D2 receptor gene Cys311 variant and schizophrenia.
Tanaka T; Igarashi S; Onodera O; Tanaka H; Fukushima N; Takahashi M; Kameda K; Tsuji S; Ihda S
Am J Med Genet; 1996 Apr; 67(2):208-11. PubMed ID: 8723049
[TBL] [Abstract][Full Text] [Related]
12. No evidence for association of dopamine D2 receptor variant (Ser311/Cys311) with major psychosis.
Sasaki T; Macciardi FM; Badri F; Verga M; Meltzer HY; Lieberman J; Howard A; Bean G; Joffe RT; Hudson CJ; Kennedy JL
Am J Med Genet; 1996 Jul; 67(4):415-7. PubMed ID: 8837713
[TBL] [Abstract][Full Text] [Related]
13. Association of structural polymorphism of the dopamine D2 receptor gene and alcoholism.
Higuchi S; Muramatsu T; Murayama M; Hayashida M
Biochem Biophys Res Commun; 1994 Nov; 204(3):1199-205. PubMed ID: 7980596
[TBL] [Abstract][Full Text] [Related]
14. No major role for the dopamine D2 receptor Ser-->Cys311 mutation in schizophrenia.
Laurent C; Bodeau-Péan S; Campion D; d'Amato T; Jay M; Dollfus S; Thibault F; Petit M; Samolyk D; Martinez M
Psychiatr Genet; 1994; 4(4):229-30. PubMed ID: 7712120
[TBL] [Abstract][Full Text] [Related]
15. Association of dopamine D2 receptor molecular variant with schizophrenia.
Arinami T; Itokawa M; Enguchi H; Tagaya H; Yano S; Shimizu H; Hamaguchi H; Toru M
Lancet; 1994 Mar; 343(8899):703-4. PubMed ID: 7907680
[TBL] [Abstract][Full Text] [Related]
16. Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations.
Liu ZW; Liu JL; An Y; Zhang L; Wang YM
Genet Mol Res; 2012 Feb; 11(1):261-70. PubMed ID: 22370928
[TBL] [Abstract][Full Text] [Related]
17. Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia.
Zahari Z; Teh LK; Ismail R; Razali SM
Psychiatr Genet; 2011 Aug; 21(4):183-9. PubMed ID: 21206399
[TBL] [Abstract][Full Text] [Related]
18. Linkage and association of a functional DRD2 variant [Ser311Cys] and DRD2 markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians.
Goldman D; Urbanek M; Guenther D; Robin R; Long JC
Am J Med Genet; 1997 Jul; 74(4):386-94. PubMed ID: 9259374
[TBL] [Abstract][Full Text] [Related]
19. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
[TBL] [Abstract][Full Text] [Related]
20. Dopamine DRD2/Cys311 is not associated with chronic schizophrenia.
Crawford F; Hoyne J; Cai X; Osborne A; Poston D; Zaglul J; Dajani N; Walsh S; Bradley R; Solomon R; Mullan M
Am J Med Genet; 1996 Sep; 67(5):483-4. PubMed ID: 8886166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
